The strategic acquisition reinforces Sebia's global leadership in specialty diagnostics LISSES, France, June 30, 2021 /PRNewswire/ -- Sebia, a leading provider of clinical protein electrophoresis equipment and reagents for diabetes and oncology detection, today announced the acquisition...
from PR Newswire: https://ift.tt/3hk3Phb
No comments:
Post a Comment